Important
Considerations
-
Time Commitment: The therapy involves multiple sessions over several weeks. You need to commit to regular appointments.
-
Individual Variability: Not everyone responds equally to neurofeedback. Some individuals may not experience significant benefits.
-
Lack of Long-Term Data: While short-term results are promising, long-term efficacy and durability remain to be fully established.
To address these and any other concerns you may have, please contact us at B6 to discuss this innovative treatment.
Principles of PRISM Neurofeedback
PRISM (Personalized Real-time fMRI-mediated neurofeedback) utilizes real-time functional Magnetic Resonance Imaging (fMRI) to provide individuals with visual feedback of their brain activity. Through operant conditioning principles, patients learn to modulate neural activity in specific brain regions or networks associated with PTSD symptoms. This personalized approach allows for precise targeting of dysfunctional circuits implicated in the pathophysiology of PTSD, thereby promoting adaptive neuroplasticity and symptom alleviation.
What is PRISM Neurofeedback
for PTSD?
PRISM (Personalized Real-time Interactive Self-Modulation) is an efficient neurofeedback therapy designed to alleviate symptoms of chronic PTSD. It is the first self-neuromodulation device for PTSD approved by the US Food and Drug Administration (FDA).
PTSD is characterized by persistent symptoms following exposure to traumatic events. These symptoms can include intrusive memories, hyperarousal, and emotional distress. Brain imaging studies have revealed specific patterns of brain activity associated with PTSD. These patterns often involve the amygdala, a region responsible for emotional processing and fear responses.
Benefits of PRISM
neurofeedback for PTSD
-
Personalized Treatment: PRISM Neurofeedback facilitates the therapy to your unique brain activity patterns. Personalization enhances treatment effectiveness by addressing specific dysregulations associated with PTSD.
-
Non-Invasive and Non-Pharmacological: PRISM does not involve medication or invasive procedures. It offers an alternative for individuals who prefer non-pharmacological approaches.
-
Patient Empowerment: PRISM encourages active participation from patients. Patients learn self-regulation techniques, which can empower them to manage their symptoms independently.
-
Promising Clinical Results: Clinical studies have shown significant reductions in PTSD symptoms in approximately 2/3 of patients. Approximately 33% experience complete remission.
What is PRISM Neurofeedback
for PTSD?
PRISM (Personalized Real-time Interactive Self-Modulation) is an efficient neurofeedback therapy designed to alleviate symptoms of chronic PTSD. It is the first self-neuromodulation device for PTSD approved by the US Food and Drug Administration (FDA).
PTSD is characterized by persistent symptoms following exposure to traumatic events. These symptoms can include intrusive memories, hyperarousal, and emotional distress. Brain imaging studies have revealed specific patterns of brain activity associated with PTSD. These patterns often involve the amygdala, a region responsible for emotional processing and fear responses.
Principles of PRISM Neurofeedback
PRISM (Personalized Real-time fMRI-mediated neurofeedback) utilizes real-time functional Magnetic Resonance Imaging (fMRI) to provide individuals with visual feedback of their brain activity. Through operant conditioning principles, patients learn to modulate neural activity in specific brain regions or networks associated with PTSD symptoms. This personalized approach allows for precise targeting of dysfunctional circuits implicated in the pathophysiology of PTSD, thereby promoting adaptive neuroplasticity and symptom alleviation.
What is PRISM Neurofeedback
for PTSD?
PRISM (Personalized Real-time Interactive Self-Modulation) is an efficient neurofeedback therapy designed to alleviate symptoms of chronic PTSD. It is the first self-neuromodulation device for PTSD approved by the US Food and Drug Administration (FDA).
PTSD is characterized by persistent symptoms following exposure to traumatic events. These symptoms can include intrusive memories, hyperarousal, and emotional distress. Brain imaging studies have revealed specific patterns of brain activity associated with PTSD. These patterns often involve the amygdala, a region responsible for emotional processing and fear responses.
Principles of PRISM Neurofeedback
PRISM (Personalized Real-time fMRI-mediated neurofeedback) utilizes real-time functional Magnetic Resonance Imaging (fMRI) to provide individuals with visual feedback of their brain activity. Through operant conditioning principles, patients learn to modulate neural activity in specific brain regions or networks associated with PTSD symptoms. This personalized approach allows for precise targeting of dysfunctional circuits implicated in the pathophysiology of PTSD, thereby promoting adaptive neuroplasticity and symptom alleviation.
Benefits of PRISM
neurofeedback for PTSD
-
Personalized Treatment: PRISM Neurofeedback facilitates the therapy to your unique brain activity patterns. Personalization enhances treatment effectiveness by addressing specific dysregulations associated with PTSD.
-
Non-Invasive and Non-Pharmacological: PRISM does not involve medication or invasive procedures. It offers an alternative for individuals who prefer non-pharmacological approaches.
-
Patient Empowerment: PRISM encourages active participation from patients. Patients learn self-regulation techniques, which can empower them to manage their symptoms independently.
-
Promising Clinical Results: Clinical studies have shown significant reductions in PTSD symptoms in approximately 2/3 of patients. Approximately 33% experience complete remission.
Important Considerations
-
Time Commitment: The therapy involves multiple sessions over several weeks. You need to commit to regular appointments.
-
Individual Variability: Not everyone responds equally to neurofeedback. Some individuals may not experience significant benefits.
-
Lack of Long-Term Data: While short-term results are promising, long-term efficacy and durability remain to be fully established.

©2024 Breakthrough6 All rights reserved
Tel. (800) 290-0175
Email: Info@breakthrough6.com

©2024 Breakthrough6 All rights reserved

What is PRISM Neurofeedback
for PTSD?
PRISM (Personalized Real-time Interactive Self-Modulation) is an efficient neurofeedback therapy designed to alleviate symptoms of chronic PTSD. It is the first self-neuromodulation device for PTSD approved by the US Food and Drug Administration (FDA).
PTSD is characterized by persistent symptoms following exposure to traumatic events. These symptoms can include intrusive memories, hyperarousal, and emotional distress. Brain imaging studies have revealed specific patterns of brain activity associated with PTSD. These patterns often involve the amygdala, a region responsible for emotional processing and fear responses.
Benefits of PRISM
neurofeedback for PTSD
Principles of PRISM
Neurofeedback
PRISM (Personalized Real-time fMRI-mediated neurofeedback) utilizes real-time functional Magnetic Resonance Imaging (fMRI) to provide individuals with visual feedback of their brain activity. Through operant conditioning principles, patients learn to modulate neural activity in specific brain regions or networks associated with PTSD symptoms. This personalized approach allows for precise targeting of dysfunctional circuits implicated in the pathophysiology of PTSD, thereby promoting adaptive neuroplasticity and symptom alleviation.
Important
Considerations
-
Personalized Treatment: PRISM Neurofeedback facilitates the therapy to your unique brain activity patterns. Personalization enhances treatment effectiveness by addressing specific dysregulations associated with PTSD.
-
Non-Invasive and Non-Pharmacological: PRISM does not involve medication or invasive procedures. It offers an alternative for individuals who prefer non-pharmacological approaches.
-
Patient Empowerment: PRISM encourages active participation from patients. Patients learn self-regulation techniques, which can empower them to manage their symptoms independently.
-
Promising Clinical Results: Clinical studies have shown significant reductions in PTSD symptoms in approximately 2/3 of patients. Approximately 33% experience complete remission.
-
Time Commitment: The therapy involves multiple sessions over several weeks. You need to commit to regular appointments.
-
Individual Variability: Not everyone responds equally to neurofeedback. Some individuals may not experience significant benefits.
-
Lack of Long-Term Data: While short-term results are promising, long-term efficacy and durability remain to be fully established.